aTYR PHARMA INC - COMMON STOCK (ATYR)

Historical Holders from Q2 2019 to Q3 2025

Symbol
ATYR on Nasdaq
Type / Class
Equity / COMMON STOCK
Shares outstanding
97,996,626
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
60,876,849
Holdings value
$43,917,863
% of all portfolios
0%
Number of holders
98
Number of buys
61
Number of sells
-64
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of aTYR PHARMA INC - COMMON STOCK (ATYR)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
FEDERATED HERMES, INC. 10.76% -39.5% $55,463,739 -$21,682,577 10,544,437 -28.1% Federated Hermes, Inc. 30 Sep 2025
BlackRock, Inc. 6.5% $29,221,482 5,763,606 BlackRock, Inc. 30 Jun 2025
VANGUARD GROUP INC 5.23% $23,601,093 4,655,048 The Vanguard Group 30 Jun 2025
Point72 Asset Management, L.P. 3.2% $9,617,297 2,845,354 Point72 Asset Management, L.P. 31 Mar 2025

Institutional Holders of aTYR PHARMA INC - COMMON STOCK (ATYR)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 60,876,849 $43,917,863 -$49,484,401 $0.7214 98
2025 Q2 66,359,568 $336,444,770 +$26,875,848 $5.07 109
2025 Q1 61,756,683 $186,507,450 +$18,904,946 $3.02 86
2024 Q4 54,865,656 $198,612,160 +$28,523,986 $3.62 77
2024 Q3 47,869,886 $84,250,295 -$378,413 $1.76 55
2024 Q2 48,121,584 $75,070,910 +$8,935,546 $1.56 44
2024 Q1 41,805,838 $81,517,658 +$1,482,921 $1.95 56
2023 Q4 41,229,482 $58,129,683 +$3,571,040 $1.41 46
2023 Q3 37,134,381 $58,673,004 +$2,049,031 $1.58 41
2023 Q2 35,668,257 $77,043,513 +$2,315,570 $2.16 41
2023 Q1 34,663,995 $72,793,910 +$35,335,611 $2.1 37
2022 Q4 18,353,420 $40,193,707 -$2,084,056 $2.19 36
2022 Q3 19,059,787 $57,179,570 +$782,338 $3 33
2022 Q2 18,767,627 $53,115,149 -$3,104,794 $2.83 34
2022 Q1 19,627,641 $105,009,778 -$6,312,765 $5.35 39
2021 Q4 20,554,611 $153,544,033 +$11,326,984 $7.47 46
2021 Q3 233,068 $2,114,000 -$353,397 $7.26 4
2021 Q2 6,787,129 $33,117,000 +$4,918,998 $4.88 23
2021 Q1 5,779,531 $25,721,000 +$251,380 $4.45 19
2020 Q4 5,763,402 $22,361,000 -$366,396 $3.88 19
2020 Q3 5,634,598 $18,198,000 +$467,508 $3.23 20
2020 Q2 5,472,169 $24,295,000 +$1,598,388 $4.44 21
2020 Q1 5,114,483 $14,319,000 +$9,326,688 $2.8 21
2019 Q4 1,793,570 $7,478,000 +$294,915 $4.17 13
2019 Q3 1,727,317 $6,046,000 +$4,183,916 $3.5 15
2019 Q2 530,377 $193,000 +$193,000 $0.364 5